Taro Pharmaceutical Industries Ltd (TARO)

115.57
NYSE : Health Care
Prev Close 116.61
Day Low/High 115.38 / 116.98
52 Wk Low/High 92.28 / 152.30
Avg Volume 101.00K
Exchange NYSE
Shares Outstanding 41.03M
Market Cap 4.78B
EPS 12.60
P/E Ratio 9.98
Div & Yield N.A. (N.A)

Latest News

Taro To Announce Third Quarter Results On February 9, 2017

Taro To Announce Third Quarter Results On February 9, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2016, after the close of market on Thursday, February 9, 2017.

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

Demographic trends that boosted big gains in prior years haven't gone away.

Taro Announces Sale Of U.S. Rights To Keveyis® To Strongbridge Biopharma Plc

Taro Announces Sale Of U.S. Rights To Keveyis® To Strongbridge Biopharma Plc

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today announced the sale of U.

Impax Searches for a New CEO

Impax Searches for a New CEO

Impax Laboratories CEO G. Frederick Wilkinson steps down amid a Department of Justice generic price-fixing investigation. J. Kevin Buchi, who joined the board last month, was tapped as interim CEO.

Bearish Bets: A Drug Maker, a Mexican Airline and Other Stocks That Look Good Short

MLNX, TARO, VLRS, DL and GIMO all were recently downgraded by TheStreet's Quant Ratings.

SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Class Action Lawsuit Filed Against Taro Pharmaceutical Industries Ltd.

SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Class Action Lawsuit Filed Against Taro Pharmaceutical Industries Ltd.

The law firm of Kessler Topaz Meltzer & Check, LLP reminds Taro Pharmaceutical Industries Ltd.

DOJ Files Charges in Generic Drug Price-Fixing Investigation

DOJ Files Charges in Generic Drug Price-Fixing Investigation

Shares of leading generics fall as more charges are expected.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCRH, BGFV, CHTR, CTS, HLT, HZO, JRVR, MOMO, NYRT, PERY, VLP Downgrades: DL, MLNX, SGMA, SPKE, TARO, VLRS Initiations: AAAP, EQBK, VYGR Read on to get TheStreet Quant Ratings' detailed report:

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Taro Pharmaceutical Industries Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of December 27, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Taro Pharmaceutical Industries Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of December 27, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Taro Pharmaceutical Industries Ltd.

TARO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Taro Pharmaceutical Industries Ltd. And A Lead Plaintiff Deadline Of December 27, 2016

TARO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Taro Pharmaceutical Industries Ltd. And A Lead Plaintiff Deadline Of December 27, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Taro Pharmaceutical Industries Ltd.

Taro Announces Appointment Of Interim CEO

Taro Announces Appointment Of Interim CEO

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announced today that its Board of Directors has appointed Mr.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Taro Pharmaceutical Industries Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of December 27, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Taro Pharmaceutical Industries Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of December 27, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Taro Pharmaceutical Industries Ltd.

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Taro Pharmaceutical Industries Ltd. To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Taro Pharmaceutical Industries Ltd. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Taro Announces New $250 Million Share Repurchase Authorization

Taro Announces New $250 Million Share Repurchase Authorization

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that its Board of Directors has approved a new $250 million share repurchase authorization of its ordinary shares.

Sun's Taro Unit Names New CEO Amid Generics Investigation

Sun's Taro Unit Names New CEO Amid Generics Investigation

The India pharma giant also purchases an 85.1% interest in Biosintez for $60 million.

TARO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Taro Pharmaceutical Industries Ltd. And A Lead Plaintiff Deadline Of December 27, 2016

TARO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Taro Pharmaceutical Industries Ltd. And A Lead Plaintiff Deadline Of December 27, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Taro Pharmaceutical Industries Ltd.

Taro Announces Appointment Of New CEO And New Board Member Nominations

Taro Announces Appointment Of New CEO And New Board Member Nominations

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announced today the appointment of Mr.

Generics Fuel Solid 3Q for Taro Pharmaceutical

Generics Fuel Solid 3Q for Taro Pharmaceutical

Days after price fixing allegations go public over generic drugs, Taro posts financials showing net sales up thanks to, yes that's right, its U.S. generic drug business.

Taro Provides Results For September 30, 2016

Taro Provides Results For September 30, 2016

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and six months ended September 30, 2016.

After Big Drop in Generics, Ride the Rebound

After Big Drop in Generics, Ride the Rebound

Investors have a buying opportunity because the damage by any criminal charges is far less than what is likely to be inflicted by the feds.

Generics Hit by Report on Pending DOJ Price Fixing Charges

Generics Hit by Report on Pending DOJ Price Fixing Charges

The DOJ's investigation has been under way for at least two years and a number of companies have reported receiving subpoenas related to the investigation.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Taro Pharmaceutical Industries Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Taro Pharmaceutical Industries Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. - TARO

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. - TARO

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Taro Pharmaceutical Industries Ltd.